Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.61
+1.36 (6.40%)
At close: Mar 9, 2026, 4:00 PM EDT
21.61
-1.00 (-4.42%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Ultragenyx Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
421174213.58132.94307.58
Upgrade
Short-Term Investments
259436363.63614.82432.61
Upgrade
Cash & Short-Term Investments
680610577.21747.76740.2
Upgrade
Cash Growth
11.47%5.68%-22.81%1.02%-38.40%
Upgrade
Accounts Receivable
15812273.3940.4528.43
Upgrade
Other Receivables
231.16.416
Upgrade
Receivables
16012574.4946.8544.43
Upgrade
Inventory
524533.9726.7716.23
Upgrade
Prepaid Expenses
463044.51-55.75
Upgrade
Restricted Cash
1372.010.86-
Upgrade
Other Current Assets
---61.66-
Upgrade
Total Current Assets
951817732.18883.9856.6
Upgrade
Property, Plant & Equipment
267292314.47285.73176.18
Upgrade
Long-Term Investments
57135199.9148.97293.86
Upgrade
Goodwill
444444.4144.4144.41
Upgrade
Other Intangible Assets
176178166.27160.11130.79
Upgrade
Other Long-Term Assets
373733.7922.3420.56
Upgrade
Total Assets
1,5321,5031,4911,5451,522
Upgrade
Accounts Payable
313942.1143.2717.14
Upgrade
Accrued Expenses
265241196.49204.68145.56
Upgrade
Current Portion of Long-Term Debt
695029.24--
Upgrade
Current Portion of Leases
121012.611.7811.07
Upgrade
Current Unearned Revenue
---1.487.61
Upgrade
Other Current Liabilities
74---
Upgrade
Total Current Liabilities
384344280.44261.21181.37
Upgrade
Long-Term Debt
1,147820862.33875.44351.79
Upgrade
Long-Term Leases
243030.5719.8130.9
Upgrade
Long-Term Unearned Revenue
----1.47
Upgrade
Long-Term Deferred Tax Liabilities
303030.0631.6733.31
Upgrade
Other Long-Term Liabilities
201712.214.821.01
Upgrade
Total Liabilities
1,6051,2411,2161,193599.84
Upgrade
Common Stock
--0.080.070.07
Upgrade
Additional Paid-In Capital
4,4514,2133,6623,1402,997
Upgrade
Retained Earnings
-4,532-3,957-3,388-2,781-2,074
Upgrade
Treasury Stock
-8-4-0.43--
Upgrade
Comprehensive Income & Other
931.08-6.57-1.4
Upgrade
Total Common Equity
-80255275.41352.49922.56
Upgrade
Minority Interest
77---
Upgrade
Shareholders' Equity
-73262275.41352.49922.56
Upgrade
Total Liabilities & Equity
1,5321,5031,4911,5451,522
Upgrade
Total Debt
1,252910934.74907.03393.76
Upgrade
Net Cash (Debt)
-515-165-157.63-10.3605.37
Upgrade
Net Cash Growth
-----26.90%
Upgrade
Net Cash Per Share
-5.22-1.82-2.14-0.158.93
Upgrade
Filing Date Shares Outstanding
96.4392.582.3470.2269.38
Upgrade
Total Common Shares Outstanding
96.492.4882.3270.269.34
Upgrade
Working Capital
567473451.75622.69675.24
Upgrade
Book Value Per Share
-0.832.763.355.0213.30
Upgrade
Tangible Book Value
-3003364.74147.98747.37
Upgrade
Tangible Book Value Per Share
-3.110.360.792.1110.78
Upgrade
Land
171716.6216.6215.49
Upgrade
Buildings
182182181.362.8-
Upgrade
Machinery
125119116.2670.2854.31
Upgrade
Construction In Progress
---189.4576.85
Upgrade
Leasehold Improvements
555858.6843.9444.08
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.